Anti-tumour immunotherapy with Vγ9Vδ2 T lymphocytes: from the bench to the bedside.

Braza, Mounia S

Anti-tumour immunotherapy with Vγ9Vδ2 T lymphocytes: from the bench to the bedside. [electronic resource] - British journal of haematology Jan 2013 - 123-32 p. digital

Publication Type: Journal Article; Review

1365-2141

10.1111/bjh.12090 doi


Adaptive Immunity
Adjuvants, Immunologic--pharmacology
Antigens, Neoplasm--immunology
CD8-Positive T-Lymphocytes--immunology
Cells, Cultured--drug effects
Clinical Trials as Topic
Dendritic Cells--immunology
Diphosphonates--pharmacology
Gene Rearrangement, delta-Chain T-Cell Antigen Receptor
Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor
Humans
Immunity, Innate
Immunologic Surveillance--immunology
Immunotherapy, Adoptive
Killer Cells, Natural--immunology
Mesenchymal Stem Cells--immunology
Neoplasms--immunology
Receptors, Antigen, T-Cell, alpha-beta--analysis
Receptors, Antigen, T-Cell, gamma-delta--analysis
T-Lymphocyte Subsets--chemistry
T-Lymphocytes, Cytotoxic--chemistry
T-Lymphocytes, Regulatory--immunology
Translational Research, Biomedical
Tumor Escape--immunology